Senabre-Gallego JM - Search Results

1

[Duration of treatment with etanercept and motives for discontinuation in a cohort of patients with rheumatic disease].

Senabre-Gallego JM, Rosas-Gómez de Salazar J, Santos-Soler G, Santos-Ramírez C, Sánchez-Barrioluengo M, Salas-Heredia E, Barber-Vallés X, Cano-Pérez C, Llahí-Vidal N, Riestra-Juán R. Senabre-Gallego JM, et al. Reumatol Clin. 2011 Nov-Dec;7(6):385-8. doi: 10.1016/j.reuma.2011.06.005. Epub 2011 Oct 24. Reumatol Clin. 2011. PMID: 22078696 Free article. Clinical Trial. Spanish.

2

[Joint Infections Due to Streptococcus agalactiae in Non Immunocompromised Adults: Presentation of Two Cases].

Valls-Pascual E, Alegre-Sancho JJ, Ivorra-Cortés J, Román-Ivorra JA, Fernández-Llanio-Comella N, Chalmeta-Verdejo I, Muñoz-Gil S, Senabre-Gallego JM. Valls-Pascual E, et al. Reumatol Clin. 2008 Jul;4(4):155-8. doi: 10.1016/S1699-258X(08)71825-4. Epub 2008 Oct 28. Reumatol Clin. 2008. PMID: 21794522 Free article. Spanish.

3

[Management of the extraglandular manifestations of primary Sjögrens syndrome].

Rosas Gómez de Salazar J, Senabre Gallego JM, Santos Ramírez C. Rosas Gómez de Salazar J, et al. Reumatol Clin. 2010 Sep;6 Suppl 2:6-11. doi: 10.1016/j.reuma.2010.06.001. Epub 2010 Aug 11. Reumatol Clin. 2010. PMID: 21794757 Free article. Spanish.

4

Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis.

Senabre-Gallego JM, Santos-Ramírez C, Santos-Soler G, Salas-Heredia E, Sánchez-Barrioluengo M, Barber X, Rosas J; AIRE-MB group. Senabre-Gallego JM, et al. Patient Prefer Adherence. 2013 Sep 23;7:961-72. doi: 10.2147/PPA.S33109. Patient Prefer Adherence. 2013. PMID: 24101863 Free PMC article. Review.

5

Practical application of acid dissociation in monitoring patients treated with adalimumab.

Llinares-Tello F, Rosas-Gómez de Salazar J, Senabre-Gallego JM, Santos-Soler G, Santos-Ramírez C, Salas-Heredia E, Barber-Vallés X, Molina-García J; AIRE-MB Group. Llinares-Tello F, et al. Rheumatol Int. 2014 Dec;34(12):1701-8. doi: 10.1007/s00296-014-3032-0. Epub 2014 May 10. Rheumatol Int. 2014. PMID: 24816715

6

Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice.

Rosas J, Llinares-Tello F, de la Torre I, Santos-Ramírez C, Senabre-Gallego JM, Valor L, Barber-Vallés X, Hernández-Flórez D, Santos-Soler G, Salas-Heredia E, Carreño L; AIRE-MB Group. Rosas J, et al. Clin Exp Rheumatol. 2014 Nov-Dec;32(6):942-8. Epub 2014 Oct 20. Clin Exp Rheumatol. 2014. PMID: 25327159

7

Analytical and clinical evaluation of a new immunoassay for therapeutic drug monitoring of etanercept.

Llinares-Tello F, Rosas-Gómez de Salazar J, Senabre-Gallego JM, Santos-Soler G, Santos-Ramírez C, Salas-Heredia E, Molina-García J; AIRE-MB Group. Llinares-Tello F, et al. Clin Chem Lab Med. 2015 Sep 1;53(10):e279-82. doi: 10.1515/cclm-2014-0898. Clin Chem Lab Med. 2015. PMID: 26021413 No abstract available.

8

[Author´s reply: “An oveview of the beneficial effects of hydrolysed collagen intake on joint and bone health and on skin ageing”].

Senabre Gallego JM, Salas Heredia E, Santos Soler G, Rosas J. Senabre Gallego JM, et al. Nutr Hosp. 2016 Feb 16;33(1):193-4. doi: 10.20960/nh.36. Nutr Hosp. 2016. PMID: 27019263 Free article. Spanish. No abstract available.

9

Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis.

Rosas J, Llinares-Tello F, Senabre-Gallego JM, Barber-Vallés X, Santos-Soler G, Salas-Heredia E, Pons Bas A, Cano Pérez C, García-Carrasco M; and the AIRE-MB Group. Rosas J, et al. Among authors: senabre gallego jm. Clin Exp Rheumatol. 2017 Jan-Feb;35(1):145-148. Epub 2016 Nov 13. Clin Exp Rheumatol. 2017. PMID: 27908311 Free article.

10

Clinical relevance of monitoring serum adalimumab levels in axial spondyloarthritis.

Senabre Gallego JM, Rosas J, Marco-Mingot M, García-Gómez JA, Santos-Soler G, Salas-Heredia E, Pons-Bas A, Barber-Vallés X, Bernal-Vidal JA, Cano-Pérez C, García-Carrasco M, Flores-Pardo E; AIRE-MB Group. Senabre Gallego JM, et al. Rheumatol Int. 2019 May;39(5):841-849. doi: 10.1007/s00296-019-04288-7. Epub 2019 Mar 21. Rheumatol Int. 2019. PMID: 30899987

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters